Jeff Jonker

Jeff Jonker currently serves as the CEO of Belharra Therapeutics, a position held since September 2021. Additionally, Jonker is a board member of the California Life Sciences Association and previously held board member roles at Metacrine, Inc. and senior advisory positions at multiple companies including Ambys Medicines and Samsara BioCapital. Jonker has extensive leadership experience, having served as President at NGM Biopharmaceuticals and Senior Vice President of Corporate and Business Development at Theravance Biopharma, Inc. Jonker's academic background includes a JD from Columbia Law School, an M.Litt. in International Security Studies from the University of St Andrews, and a BA from Claremont McKenna College.